UNITAXEL Inj. 100mg/16.67mL Concentrate for Solution for Infusion

Manufacturer
Korea United Pharm. Inc.(KOREA,SOUTH)

Registraction Number
MAL19126021AZ

Content:

• Active Ingredient: Paclitaxel 100 mg
• Solvent: Dehydrated Alcohol (as solvent) – q.s.to 16.67 mL

• Breast Cancer: Used in the treatment of metastatic breast cancer.
• Lung Cancer: Treats non-small cell lung cancer.
• Ovarian Cancer: Used for ovarian cancer treatment.
• Kaposi's Sarcoma: Treats Kaposi's sarcoma in patients with AIDS.
• Other Cancers: May be used for other types of cancer as determined by a healthcare professional.

1. Dosage: The dosage should be determined by a healthcare professional based on the patient's condition and needs.
2. Administration: Administer intravenously as directed by a healthcare professional.
3. Monitoring: Regular monitoring by a healthcare professional is recommended to assess the effectiveness and any potential side effects.
4. Storage: Store below 30°C and protect from light. It is stable for 27 hours at room temperature below 30°C in 0.9% sodium chloride solution, 5% glucose solution, or a mixture of both.